Patents by Inventor Christopher T. Saeui

Christopher T. Saeui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11827663
    Abstract: Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biosynthetic pathway and methods of treating a disease using the inhibitors.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: November 28, 2023
    Assignee: The Johns Hopkins University
    Inventors: Kevin J. Yarema, Christopher T. Saeui, Alfredo Quinones-Hinojosa, Sagar Ramesh Shah
  • Publication number: 20210269468
    Abstract: Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biosynthetic pathway and methods of treating a disease using the inhibitors.
    Type: Application
    Filed: December 18, 2020
    Publication date: September 2, 2021
    Inventors: Kevin J. Yarema, Christopher T. Saeui, Alfredo Quinones-Hinojosa, Sagar Ramesh Shah
  • Patent number: 10899784
    Abstract: Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biosynthetic pathway and methods of treating a disease using the inhibitors.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: January 26, 2021
    Assignee: The Johns Hopkins University
    Inventors: Kevin J. Yarema, Christopher T. Saeui, Alfredo Quinones-Hinojosa, Sagar Ramesh Shah
  • Publication number: 20180148468
    Abstract: Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biosynthetic pathway and methods of treating a disease using the inhibitors.
    Type: Application
    Filed: August 14, 2015
    Publication date: May 31, 2018
    Inventors: Kevin J. Yarema, Christopher T. Saeui, Alfredo Quinones-Hinojosa, Sagar Ramesh Shah